QA: Castle Biosciences INC in us_health_services/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001447362_2022_Castle_Biosciences_INC.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001447362, Castle Biosciences INC

  xvar xval
0 IntangibleAssets 0
1 AssetsNonCurrent 9,098,000
2 AssetsCurrent 353,743,000
3 PropertyPlantAndEquipment 9,501,000
4 remainder_Assets 90,230,000
5 LongTermLiabilities 7,024,000
6 LiabilitiesCurrent 25,521,000
7 remainder_Liabilities 18,287,000
8 LaborExpense 0
9 CostOfGoodsAndServicesSold 15,822,000
10 GeneralAndAdministrativeExpense 86,738,000
11 GoodwillImpairmentLoss 0
12 OperatingCostsAndExpenses 0
13 DepreciationDepletionAndAmortization 0
14 SellingAndMarketingExpense 0
15 ResearchAndDevelopmentExpense 29,646,000
16 remainder_Expenses -6,761,000
17 remainder_Revenues 94,085,000
18 remainder_NetIncome 68,000
19 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 462,572,000
1 Liabilities 50,832,000
2 Expenses 125,445,000
3 Revenues 94,085,000
4 StockholdersEquity 411,740,000
5 NetIncome -31,292,000
6 ComprehensiveNetIncome -31,292,000
7 BaseVar 366,501,000
8 EconomicCapitalRatiobeforeLimitedLiability 2.20
9 EconomicCapitalRatio 2.52

Edgar->Model Mapping

Feature Distribution

Change over Time